Saliva test could improve diabetes control and treatment

July 23, 2018, Frontiers
Credit: CC0 Public Domain

Diabetes assessment currently relies on measurement of blood sugar levels—but a simple saliva sample could replace this, says new research. The study, published in Frontiers in Physiology and the most comprehensive of its kind to date, finds that proteins in saliva reflect high blood sugar and associated disease processes in young patients with type 1 diabetes, long before the appearance of clinical symptoms. This could lead to better prediction and prevention of long-term complications of the disease.

People with type 1 diabetes produce too little insulin. This hormone is required for the body to use sugar for energy, so lack of insulin causes unused sugar to accumulate in the blood. This excess sugar in turn leads to complications like cardiovascular, kidney, eye and nerve damage.

With no known cure for type 1 diabetes, the key to preventing these complications is careful control of blood sugar levels. This is achieved with insulin injections—balanced with lifestyle factors like diet and exercise—and requires regular blood testing to monitor sugar control.

But this invasive monitoring can be problematic, particularly in children and adolescents.

"Blood collection through repeated sampling causes discomfort and hinders patients' compliance," explains study co-author Professor Heleni Vastardis of NKU Athens School of Dentistry. "Easy, simple, painless, non-invasive saliva collection is the most attractive diagnostic medium when examining children."

Our saliva contains thousands of proteins produced by our salivary glands and gums, with important roles like healing, digestion and fighting disease. Previous research shows that the amounts of each of these proteins—collectively called the "salivary proteome"—differ between healthy people and those with diabetes.

Vastardis and colleagues see great potential in this finding. "Saliva is considered a mirror of the body's health and disease and a possible game changer in healthcare and clinical practice," she says.

Their new study is the most comprehensive characterization of the salivary proteome to date. It analysed saliva samples from young type 1 diabetics with satisfactory or poor blood sugar control and from matched healthy subjects, using a highly sensitive technique to identify and quantify more than 2,000 different proteins.

The researchers found that young type 1 diabetics with good blood sugar control had similar saliva protein profiles to non-diabetics.

In contrast, young people with poorly controlled type 1 diabetes showed a very different saliva protein profile. The differences were in proteins known to have key roles in inflammation, clotting and blood vessel function—processes that are disrupted by high and thereby underly the major long-term complications of diabetes.

Crucially, none of these young patients yet had any clinical signs of eye, kidney or nerve damage. "In other words, the signs of diabetic pathology are already in place way before manifestation of clinical complications," Vastardis points out.

This suggests that the diabetic salivary proteome could be used to predict complications—and help prevent them. "Salivary diagnostics enable the assessment of asymptomatic diabetic patients and the identification of high-risk patients likely to face diabetic complications. This knowledge may offer access to novel points of intervention."

To demonstrate this principle, the group used their results to identify a potential new preventive treatment for young patients with poor diabetic control. By searching a gene database, they found a drug candidate capable of reversing the salivary proteome changes associated with high .

This proof-of-concept study demonstrates the power of salivary analysis in diabetes research—and soon in the diabetes clinic, Vastardis believes.

"We envision that in the near future we will be able to diagnose and monitor therapeutic strategies in with only a drop of , through ultra-sensitive and highly specific techniques such as the Multiple Reaction Monitoring used in our study as well as real-time, non-invasive, salivary glucose monitoring devices."

"However, larger cohorts are required to completely utilize the information and to account for the potential variance."

Explore further: Artificial pancreas helps hospitalized type 2 diabetics

More information: Eftychia Pappa et al, Saliva Proteomics Analysis Offers Insights on Type 1 Diabetes Pathology in a Pediatric Population, Frontiers in Physiology (2018). DOI: 10.3389/fphys.2018.00444

Related Stories

Artificial pancreas helps hospitalized type 2 diabetics

June 26, 2018
(HealthDay)—Using an artificial pancreas can help hospitalized patients with type 2 diabetes maintain good blood sugar control, a new study suggests.

Brain scans show why some type 1 diabetics miss low blood sugar cues

February 2, 2018
The brains of people with type 1 diabetes react differently to low blood sugar compared with healthy adults, say Yale researchers.

Researchers change clinical practice for infants with diabetes

June 8, 2018
It is not necessary to treat diabetic infants with insulin syringes. This will be new clinical practice after a recent study, now published in Lancet Diabetes & Endocrinology in which researchers from Bergen and Exeter tested ...

Saliva test might someday replace needle prick for diabetics

July 12, 2014
A new type of sensor for people with diabetes is being developed to measure sugar levels in the body using saliva instead of blood, researchers report.

Junk food causes similar high blood sugar levels as type 2 diabetes

May 10, 2016
A junk food diet can cause as much damage to the kidney as diabetes, according to a study published in Experimental Physiology.

Recommended for you

A novel insulin accelerant

October 17, 2018
Insulin levels rise after eating a meal, signaling uptake of circulating glucose by skeletal muscle. In individuals with diabetes this process is often impaired—a condition known as insulin resistance.

Fat tissue may play a crucial role in the progression of diabetes, challenging long established notions

October 12, 2018
A new study by Australian researchers, out today, is challenging what we know about the causes of diabetes. The new research points to fat tissue as a source of disease, and widens our understanding beyond the traditional ...

Does breastfeeding hormone protect against type 2 diabetes?

October 12, 2018
(HealthDay)—The hormone prolactin—most commonly associated with breastfeeding—may play a role in reducing the risk of type 2 diabetes, a new study suggests.

Markers of dairy fat consumption linked to lower risk of type two diabetes

October 10, 2018
Higher levels of biomarkers of dairy fat consumption are associated with a lower risk of developing type 2 diabetes, according to new research published today in PLOS Medicine. The study, in more than 60,000 adults, was undertaken ...

Planned intermittent fasting may help reverse type 2 diabetes, suggest doctors

October 10, 2018
Planned intermittent fasting may help to reverse type 2 diabetes, suggest doctors writing in the journal BMJ Case Reports after three patients in their care, who did this, were able to cut out the need for insulin treatment ...

New discovery restores insulin cell function in type 2 diabetes

October 8, 2018
By blocking a protein, VDAC1, in the insulin-producing beta cells, it is possible to restore their normal function in case of type 2 diabetes. In preclinical experiments, the researchers behind a new study have also shown ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.